128 related articles for article (PubMed ID: 15313392)
21. Expression of epiregulin and amphiregulin in the rat ovary.
Sekiguchi T; Mizutani T; Yamada K; Kajitani T; Yazawa T; Yoshino M; Miyamoto K
J Mol Endocrinol; 2004 Aug; 33(1):281-91. PubMed ID: 15291759
[TBL] [Abstract][Full Text] [Related]
22. Novel function of ovarian growth factors: combined studies by DNA microarray, biochemical and physiological approaches.
Ben-Ami I; Freimann S; Armon L; Dantes A; Ron-El R; Amsterdam A
Mol Hum Reprod; 2006 Jul; 12(7):413-9. PubMed ID: 16714369
[TBL] [Abstract][Full Text] [Related]
23. Human corneal epithelial cell proliferation by epiregulin and its cross-induction by other EGF family members.
Morita S; Shirakata Y; Shiraishi A; Kadota Y; Hashimoto K; Higashiyama S; Ohashi Y
Mol Vis; 2007 Nov; 13():2119-28. PubMed ID: 18079685
[TBL] [Abstract][Full Text] [Related]
24. Cripto monoclonal antibodies.
Hu XF; Xing PX
Drug News Perspect; 2005 Jun; 18(5):293-303. PubMed ID: 16193101
[TBL] [Abstract][Full Text] [Related]
25. Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells.
Ji C; Cao C; Lu S; Kivlin R; Amaral A; Kouttab N; Yang H; Chu W; Bi Z; Di W; Wan Y
Cancer Chemother Pharmacol; 2008 Oct; 62(5):857-65. PubMed ID: 18214481
[TBL] [Abstract][Full Text] [Related]
26. Expression of the epidermal growth factor system in endometrioid endometrial cancer.
Ejskjaer K; Sørensen BS; Poulsen SS; Forman A; Nexø E; Mogensen O
Gynecol Oncol; 2007 Jan; 104(1):158-67. PubMed ID: 16962163
[TBL] [Abstract][Full Text] [Related]
27. Luteinizing hormone-induced up-regulation of ErbB-2 is insufficient stimulant of growth and invasion in ovarian cancer cells.
Warrenfeltz SW; Lott SA; Palmer TM; Gray JC; Puett D
Mol Cancer Res; 2008 Nov; 6(11):1775-85. PubMed ID: 19010824
[TBL] [Abstract][Full Text] [Related]
28. Amphiregulin and epidermal growth factor receptor expression in human malignant fibrous histiocytoma of soft tissues.
Yamamoto T; Fujita I; Akisue T; Marui T; Nakatani T; Kawamoto T; Hitora T; Nagira K; Matsumoto K; Kurosaka M
Anticancer Res; 2004; 24(2C):1307-10. PubMed ID: 15154665
[TBL] [Abstract][Full Text] [Related]
29. Regulated expression of ADAM8 (a disintegrin and metalloprotease domain 8) in the mouse ovary: evidence for a regulatory role of luteinizing hormone, progesterone receptor, and epidermal growth factor-like growth factors.
Sriraman V; Eichenlaub-Ritter U; Bartsch JW; Rittger A; Mulders SM; Richards JS
Biol Reprod; 2008 Jun; 78(6):1038-48. PubMed ID: 18287572
[TBL] [Abstract][Full Text] [Related]
30. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of betacellulin and heparin-binding EGF-like growth factor in cultured zebrafish ovarian follicle cells by EGF family ligands.
Tse AC; Ge W
Comp Biochem Physiol A Mol Integr Physiol; 2009 May; 153(1):13-7. PubMed ID: 19000772
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas.
D'Antonio A; Losito S; Pignata S; Grassi M; Perrone F; De Luca A; Tambaro R; Bianco C; Gullick WJ; Johnson GR; Iaffaioli VR; Salomon DS; Normanno N
Int J Oncol; 2002 Nov; 21(5):941-8. PubMed ID: 12370739
[TBL] [Abstract][Full Text] [Related]
33. Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer.
Macleod K; Mullen P; Sewell J; Rabiasz G; Lawrie S; Miller E; Smyth JF; Langdon SP
Cancer Res; 2005 Aug; 65(15):6789-800. PubMed ID: 16061661
[TBL] [Abstract][Full Text] [Related]
34. Amphiregulin is much more abundantly expressed than transforming growth factor-alpha and epidermal growth factor in human follicular fluid obtained from patients undergoing in vitro fertilization-embryo transfer.
Inoue Y; Miyamoto S; Fukami T; Shirota K; Yotsumoto F; Kawarabayashi T
Fertil Steril; 2009 Apr; 91(4):1035-41. PubMed ID: 18325497
[TBL] [Abstract][Full Text] [Related]
35. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells.
Castillo J; Erroba E; Perugorría MJ; Santamaría M; Lee DC; Prieto J; Avila MA; Berasain C
Cancer Res; 2006 Jun; 66(12):6129-38. PubMed ID: 16778186
[TBL] [Abstract][Full Text] [Related]
36. Expression and regulation of luteinizing hormone/human chorionic gonadotropin receptors in ovarian cancer and its correlation to human chorionic gonadotropin-doxorubicin sensitivity.
Gebauer G; Mueller N; Fehm T; Berkholz A; Beck EP; Jaeger W; Licht P
Am J Obstet Gynecol; 2004 Jun; 190(6):1621-8; discussion 1628. PubMed ID: 15284756
[TBL] [Abstract][Full Text] [Related]
37. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
38. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
39. Actions of epidermal growth factor receptor/mitogen-activated protein kinase and protein kinase C signaling in granulosa cells from Gallus gallus are dependent upon stage of differentiation.
Woods DC; Haugen MJ; Johnson AL
Biol Reprod; 2007 Jul; 77(1):61-70. PubMed ID: 17409374
[TBL] [Abstract][Full Text] [Related]
40. Integrin alphavbeta3 mediates upregulation of epidermal growth-factor receptor expression and activity in human ovarian cancer cells.
Lössner D; Abou-Ajram C; Benge A; Reuning U
Int J Biochem Cell Biol; 2008; 40(12):2746-61. PubMed ID: 18577466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
